UPDATE 1-Teva buys NuPathe to expand central nervous system business

TEL AVIV, Jan 21 (Reuters) - Teva Pharmaceutical Industries will acquire NuPathe Inc for $3.65 per share in cash, or $144 million, to expand its portfolio of medicines to treat conditions affecting...

from Reuters: Mergers News http://ift.tt/KC1pJ8